At a glance
- Originator Nonindustrial source
- Class Antiepileptic drugs; Neuroprotectants; Oxazines
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Seizures
Most Recent Events
- 21 Dec 1999 No-Development-Reported for Seizures in Italy (Unknown route)
- 01 May 1997 New profile
- 01 May 1997 Preclinical development for Seizures in Italy (Unknown route)